Sickle Cell Trait Carriage: Imbalanced Distribution of IgG Subclass Antibodies Reactive to Plasmodium Falciparum Family-specific MSP2 Peptides in Serum Samples from Gabonese Children
Overview
Authors
Affiliations
Several mechanisms have been proposed for explaining the protection of young children with hemoglobin AS from severe Plasmodium falciparum malaria. In a previous study carried out in Gabon, we have shown an association between hemoglobin AS carriage and a greater P. falciparum infection complexity. In the present study, we have investigated the presence and fine specificity of merozoite surface protein 2 (MSP2) reactive antibodies using different peptides covering conserved and polymorphic regions (Blocks 1-3) of P. falciparum MSP2 molecules. A cross-sectional study was conducted in the city of Bakoumba (Gabon), where malaria is hyperendemic with perennial P. falciparum transmission. Among the 641 children included, 135 were heterozygous for the sickle cell trait (HbAS). There was no significant difference in age distribution (mean age: 5 years, 0.5-11 years) and sex ratio in both hemoglobin groups (HbAA vs. HbAS). Blood group O was, however, associated with the sickle cell trait (P=0.02). P. falciparum isolates obtained from children with HbAS had a trend to higher infection complexity before the age of 5 years. Plasma samples were tested for the presence of antibodies to the different MSP2 peptides. Total IgG antibodies with a predominant reactivity against the FC27 type (the predominant P. falciparum MSP2 genotype) were found in serum samples from both groups. The profile of the IgG subclasses varied according to the hemoglobin phenotype. IgG3 and IgG2 were predominantly detected in plasma samples from HbAS children, whereas mainly IgG3 was found in children with HbAA. The role of the high multiclonal carriage associated with high family-specific antibodies reactive to MSP2 in HbAS children with asymptomatic P. falciparum parasitism is discussed.
A comprehensive study of epitopes and immune reactivity among Plasmodium species.
Kalkal M, Kalkal A, Dhanda S, Das E, Pande V, Das J BMC Microbiol. 2022; 22(1):74.
PMID: 35277125 PMC: 8913861. DOI: 10.1186/s12866-022-02480-7.
Tonkin-Hill G, Ruybal-Pesantez S, Tiedje K, Rougeron V, Duffy M, Zakeri S PLoS Genet. 2021; 17(2):e1009269.
PMID: 33630855 PMC: 7906310. DOI: 10.1371/journal.pgen.1009269.
Evidence of strain structure in gene repertoires in children from Gabon, West Africa.
Day K, Artzy-Randrup Y, Tiedje K, Rougeron V, Chen D, Rask T Proc Natl Acad Sci U S A. 2017; 114(20):E4103-E4111.
PMID: 28461509 PMC: 5441825. DOI: 10.1073/pnas.1613018114.
Guiyedi V, Becavin C, Herbert F, Gray J, Cazenave P, Kombila M Malar J. 2015; 14:162.
PMID: 25889717 PMC: 4419484. DOI: 10.1186/s12936-015-0658-7.
The genetic control of immunity to Plasmodium infection.
Grant A, Roussilhon C, Paul R, Sakuntabhai A BMC Immunol. 2015; 16:14.
PMID: 25887595 PMC: 4374205. DOI: 10.1186/s12865-015-0078-z.